Middle East & Africa Lung Cancer Screening Market Forecast to 2030 – Regional Analysis – by Cancer Type [Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer], Technology [Low-Dose Computed Tomography (LDCT), Chest X-Ray, Liquid Biopsy, and Other

Middle East & Africa Lung Cancer Screening Market Forecast to 2030 – Regional Analysis – by Cancer Type [Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer], Technology [Low-Dose Computed Tomography (LDCT), Chest X-Ray, Liquid Biopsy, and Others], Age Group (50 & Older and Below 50), and End User (Hospitals, Diagnostic Centers, and Others)

The Middle East & Africa lung cancer screening market is expected to grow from US$ 17.52 million in 2022 to US$ 30.11 million by 2030. It is estimated to grow at a CAGR of 7.0% from 2022 to 2030.

Collaboration With Regional Hospitals and Clinics Fuel Middle East & Africa Lung Cancer Screening Market

Amid growing healthcare awareness in the region, lung cancer screening providers in the region has ample opportunities. These include collaborating with regional hospitals and clinics through which they can offer accessible lung cancer screening and leveraging telemedicine for remote areas. This approach not only detects lung cancer early but also improves patient outcomes, filling a crucial gap in the region’s healthcare. By aligning with the rising demand for preventive care, these providers can establish a foothold in a promising market, ultimately contributing to enhanced public health and well-being across the region.

Middle East & Africa Lung Cancer Screening Market Overview

The Middle East & Africa lung cancer screening market has been segmented into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. Saudi Arabia is expected to account for the largest market share and is expected to develop moderately in the Middle East & Africa. Factors that are driving the Middle East & Africa lung cancer screening market growth are increasing awareness of screening & diagnosis and growing initiatives by government and clinical & research institute. Iran, Iraq, Turkey, Kuwait, Qatar, Kenya, and Israel are among the major contributors to the lung cancer screening market in the Rest of Middle East & Africa. According to a report published in NCBI, in Qatar, lung cancer is a prevalent health condition, which can be attributed to the rising use of tobacco. The survival rate among lung cancer patients in Qatar is lower than the global average. Further, various factors such as distant metastasis, smoking status, and treatment history are associated with lung cancer survival in Qatar. Due to low survival rates, the Qatari government highly recommends screening for lung cancer. The Turkish Society of Lung Cancer had established a “Tobacco Control Committee” to promote tobacco control throughout Turkey and make the public aware of lung cancer as well as the need for screening. These factors propel the demand for lung cancer screening procedures in the Rest of the Middle East & Africa

Middle East & Africa Lung Cancer Screening Market Revenue and Forecast to 2030 (US$ Million)

Middle East & Africa Lung Cancer Screening Market Segmentation

The Middle East & Africa lung cancer screening market is segmented into cancer type, technology, age group, end user, and country.

Based on cancer type, the Middle East & Africa lung cancer screening market is segmented into non–small cell lung cancer (NSCLC), and small cell lung cancer. The non–small cell lung cancer (NSCLC) segment held a larger share of the Middle East & Africa lung cancer screening market in 2022.

Based on technology, the Middle East & Africa lung cancer screening market is segmented into chest X-ray, low dose computed tomography (LDCT), liquid biopsy, and others. Chest X-ray segment held the largest share of the Middle East & Africa lung cancer screening market in 2022.

Based on age group, the Middle East & Africa lung cancer screening market is segmented into 50 and older, and below 50. 50 and older segment held the larger share of the Middle East & Africa lung cancer screening market in 2022.

Based on end user, the Middle East & Africa lung cancer screening market is segmented into hospital, diagnostic centre, and others. Hospital segment held the largest share of the Middle East & Africa lung cancer screening market in 2022.

Based on country, the Middle East & Africa lung cancer screening market is segmented into South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa. The Rest of Middle East & Africa dominated the Middle East & Africa lung cancer screening market in 2022.

Siemens AG, Koninklijke Philips NV, Canon Inc, Medtronic, GE HealthCare, and Nuance Communications Inc are some of the leading companies operating in the Middle East & Africa lung cancer screening market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa Lung Cancer Screening Market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in Middle East & Africa Lung Cancer Screening Market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Middle East & Africa Market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.